» Articles » PMID: 36116040

Mutation Update for the ACTN2 Gene

Abstract

ACTN2 encodes alpha-actinin-2, a protein expressed in human cardiac and skeletal muscle. The protein, located in the sarcomere Z-disk, functions as a link between the anti-parallel actin filaments. This important structural protein also binds N-terminal titins, and thus contributes to sarcomere stability. Previously, ACTN2 mutations have been solely associated with cardiomyopathy, without skeletal muscle disease. Recently, however, ACTN2 mutations have been associated with novel congenital and distal myopathy. Previously reported variants are in varying locations across the gene, but the potential clustering effect of pathogenic locations is not clearly understood. Further, the genotype-phenotype correlations of these variants remain unclear. Here we review the previously reported ACTN2-related molecular and clinical findings and present an additional variant, c.1840-2A>T, that further expands the mutation and phenotypic spectrum. Our results show a growing body of clinical, genetic, and functional evidence, which underlines the central role of ACTN2 in the muscle tissue and myopathy. However, limited segregation and functional data are available to support the pathogenicity of most previously reported missense variants and clear-cut genotype-phenotype correlations are currently only demonstrated for some ACTN2-related myopathies.

Citing Articles

Clinical and imaging spectrum of non-congenital dominant ACTN2 myopathy.

Iruzubieta P, Verdu-Diaz J, Topf A, Luce L, Claeys K, De Ridder W J Neurol. 2025; 272(2):150.

PMID: 39812845 DOI: 10.1007/s00415-025-12893-9.


Accelerated Sarcopenia Phenotype in the DJ-1/-Knockout Zebrafish.

Rostad K, Trognitz T, Froyset A, Bifulco E, Fladmark K Antioxidants (Basel). 2025; 13(12.

PMID: 39765837 PMC: 11673048. DOI: 10.3390/antiox13121509.


Screening of potential regulatory genes in carotid atherosclerosis vascular immune microenvironment.

Zhang Y, Zhang L, Jia Y, Fang J, Zhang S, Hou X PLoS One. 2024; 19(12):e0307904.

PMID: 39652562 PMC: 11627393. DOI: 10.1371/journal.pone.0307904.


Exome sequencing data reanalysis of 200 hypertrophic cardiomyopathy patients: the HYPERGEN French cohort 5 years after the initial analysis.

Jaouadi H, Morel V, Martel H, Lindenbaum P, de la Chapelle L, Herbane M Front Med (Lausanne). 2024; 11:1480947.

PMID: 39554508 PMC: 11565434. DOI: 10.3389/fmed.2024.1480947.


Protein-extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation.

Ranta-Aho J, Felice K, Jonson P, Sarparanta J, Yvorel C, Harzallah I Ann Clin Transl Neurol. 2024; 11(9):2392-2405.

PMID: 39095936 PMC: 11537131. DOI: 10.1002/acn3.52154.


References
1.
Xiang J, Peng J, Baxter S, Peng Z . AutoPVS1: An automatic classification tool for PVS1 interpretation of null variants. Hum Mutat. 2020; 41(9):1488-1498. DOI: 10.1002/humu.24051. View

2.
Inoue M, Noguchi S, Sonehara K, Nakamura-Shindo K, Taniguchi A, Kajikawa H . A recurrent homozygous ACTN2 variant associated with core myopathy. Acta Neuropathol. 2021; 142(4):785-788. PMC: 8423689. DOI: 10.1007/s00401-021-02363-7. View

3.
Ribeiro Jr E, Pinotsis N, Ghisleni A, Salmazo A, Konarev P, Kostan J . The structure and regulation of human muscle α-actinin. Cell. 2014; 159(6):1447-60. PMC: 4259493. DOI: 10.1016/j.cell.2014.10.056. View

4.
Savarese M, Palmio J, Poza J, Weinberg J, Olive M, Cobo A . Actininopathy: A new muscular dystrophy caused by ACTN2 dominant mutations. Ann Neurol. 2019; 85(6):899-906. DOI: 10.1002/ana.25470. View

5.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View